Skip to main content
Erschienen in: Abdominal Radiology 1/2018

21.08.2017

LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents

verfasst von: Cynthia Santillan, Kathryn Fowler, Yuko Kono, Victoria Chernyak

Erschienen in: Abdominal Radiology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) was designed to standardize the interpretation and reporting of observations seen on studies performed in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS algorithm guides radiologists through the process of categorizing observations on a spectrum from definitely benign to definitely HCC. Major features are the imaging features used to categorize observations as LI-RADS 3 (intermediate probability of malignancy), LIRADS 4 (probably HCC), and LI-RADS 5 (definite HCC). Major features include arterial phase hyperenhancement, washout appearance, enhancing capsule appearance, size, and threshold growth. Observations that have few major criteria are assigned lower categories than those that have several, with the goal of preserving high specificity for the LR-5 category of Definite HCC. The goal of this paper is to discuss LI-RADS major features, including definitions, rationale for selection as major features, and imaging examples.
Literatur
4.
Zurück zum Zitat Bruix J, Sherman M, American D (2011) Association for the Study of Liver, Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral Bruix J, Sherman M, American D (2011) Association for the Study of Liver, Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wald C, et al. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382CrossRefPubMed Wald C, et al. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382CrossRefPubMed
6.
Zurück zum Zitat Choi JW, et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker. Radiology 267(3):776–786CrossRefPubMed Choi JW, et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker. Radiology 267(3):776–786CrossRefPubMed
7.
Zurück zum Zitat Hanna RF, et al. (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28(3):747–769CrossRefPubMed Hanna RF, et al. (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28(3):747–769CrossRefPubMed
8.
Zurück zum Zitat European Association for the Study of the Liver, R. European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943CrossRef European Association for the Study of the Liver, R. European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943CrossRef
9.
Zurück zum Zitat Matsui O, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36(3):264–272CrossRefPubMedPubMedCentral Matsui O, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36(3):264–272CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Muto J, et al. (2015) Review of angiogenesis in hepatocellular carcinoma. Hepatol Res 45(1):1–9CrossRefPubMed Muto J, et al. (2015) Review of angiogenesis in hepatocellular carcinoma. Hepatol Res 45(1):1–9CrossRefPubMed
11.
Zurück zum Zitat Li R, Cai P, Ma KS, et al. (2016) Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma. Sci Rep 26(6):267–272 Li R, Cai P, Ma KS, et al. (2016) Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma. Sci Rep 26(6):267–272
12.
Zurück zum Zitat Iavarone M, Piscaglia F, Vavassori S, et al. (2013) Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol 58(6):1188–1193CrossRefPubMed Iavarone M, Piscaglia F, Vavassori S, et al. (2013) Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol 58(6):1188–1193CrossRefPubMed
13.
Zurück zum Zitat Chen LD, Xu H, Xie XY, et al. (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81(971):881–889CrossRefPubMed Chen LD, Xu H, Xie XY, et al. (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81(971):881–889CrossRefPubMed
14.
Zurück zum Zitat Zhao YJ, Chen W, Wu DS, Zhang WY, Zheng LR (2016) Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings. Abdom Radiol 41(5):978–989CrossRef Zhao YJ, Chen W, Wu DS, Zhang WY, Zheng LR (2016) Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings. Abdom Radiol 41(5):978–989CrossRef
15.
Zurück zum Zitat Liu YI, et al. (2013) Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol 200(1):84–89CrossRefPubMed Liu YI, et al. (2013) Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol 200(1):84–89CrossRefPubMed
16.
Zurück zum Zitat Pawlik TM, et al. (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11(9):1086–1092CrossRefPubMed Pawlik TM, et al. (2005) Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11(9):1086–1092CrossRefPubMed
17.
Zurück zum Zitat Forner A, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47(1):97–104CrossRefPubMed Forner A, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47(1):97–104CrossRefPubMed
18.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273(1):30–50CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273(1):30–50CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kelekis NL, et al. (1998) Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 170(4):1005–1013CrossRefPubMed Kelekis NL, et al. (1998) Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 170(4):1005–1013CrossRefPubMed
20.
Zurück zum Zitat Freeny PC, Baron RL, Teefey SA (1992) Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology 182(1):143–148CrossRefPubMed Freeny PC, Baron RL, Teefey SA (1992) Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology 182(1):143–148CrossRefPubMed
21.
Zurück zum Zitat Kadoya M, et al. (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183(3):819–825CrossRefPubMed Kadoya M, et al. (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183(3):819–825CrossRefPubMed
22.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–654CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–654CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Jeong YY, Mitchell DG, Kamishima T (2002) Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327–1334CrossRefPubMed Jeong YY, Mitchell DG, Kamishima T (2002) Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327–1334CrossRefPubMed
24.
Zurück zum Zitat Taouli B, et al. (2005) Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 29(4):425–429CrossRefPubMed Taouli B, et al. (2005) Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 29(4):425–429CrossRefPubMed
25.
Zurück zum Zitat Kubota K, et al. (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 48(3):581–586CrossRefPubMed Kubota K, et al. (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 48(3):581–586CrossRefPubMed
Metadaten
Titel
LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents
verfasst von
Cynthia Santillan
Kathryn Fowler
Yuko Kono
Victoria Chernyak
Publikationsdatum
21.08.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1291-4

Weitere Artikel der Ausgabe 1/2018

Abdominal Radiology 1/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.